Ester García‐Pras
Impact in
- Hepatology top 1%
- Liver Disease and Transplantation
- Liver physiology and pathology
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 15
- Liver Disease and Transplantation 11
- Liver physiology and pathology 3
- Hepatitis C virus research 3
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Epidemiology 11
- Liver Disease Diagnosis and Treatment 11
- Hepatitis B Virus Studies 3
- Co-authors
- Mercedes Fernández (14 shared papers)Marc Mejías (12 shared papers)Jaime Bosch (10 shared papers)Carolina Tiani (3 shared papers)Raúl Méndez (6 shared papers)Rosa Miquel (1 shared paper)Javier González Gallego (10 shared papers)Juan Carlos García‐Pagán (2 shared papers)
- Journals
- Journal of Hepatology (5 papers)Hepatology (4 papers)Gut (2 papers)Liver International (1 paper)Cancers (1 paper)
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
Ester García‐Pras
22 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 66
- Hepatology 650
- Epidemiology 561
- Surgery 280
- Pharmacology 48
- Cancer Research 81
Countries citing papers authored by Ester García‐Pras
This map shows the geographic impact of Ester García‐Pras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ester García‐Pras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ester García‐Pras more than expected).
Fields of papers citing papers by Ester García‐Pras
This network shows the impact of papers produced by Ester García‐Pras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ester García‐Pras. The network helps show where Ester García‐Pras may publish in the future.
Co-authors
The 25 scholars most cited alongside Ester García‐Pras, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 244 | |
| 2 | 2007 | 139 | |
| 3 | 2010 | 78 | |
| 4 | 2015 | 72 | |
| 5 | 2008 | 68 | |
| 6 | 2020 | 60 | |
| 7 | 2021 | 47 | |
| 8 | 2007 | 46 | |
| 9 | 2014 | 45 | |
| 10 | 2014 | 43 | |
| 11 | 2006 | 42 | |
| 12 | 2012 | 35 | |
| 13 | 2021 | 28 | |
| 14 | 2008 | 26 | |
| 15 | 2009 | 21 | |
| 16 | 2007 | 19 | |
| 17 | 2016 | 13 | |
| 18 | 2021 | 9 | |
| 19 | 2017 | 7 | |
| 20 | 2016 | 2 |
About Ester García‐Pras
Ester García‐Pras is a scholar working on Hepatology, Epidemiology, Surgery, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 23 papers that have together received 1.0k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (11 papers), Liver Disease and Transplantation (11 papers), Organ Transplantation Techniques and Outcomes (5 papers), Liver physiology and pathology (3 papers), Hepatitis B Virus Studies (3 papers), Hepatitis C virus research (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Hepatology (650 citations), Epidemiology (561 citations), Surgery (280 citations), Pharmacology (48 citations) and Cancer Research (81 citations). Ester García‐Pras has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Mercedes Fernández, Marc Mejías, Jaime Bosch, Carolina Tiani, Raúl Méndez, Rosa Miquel, Javier González Gallego, Juan Carlos García‐Pagán, Annalisa Berzigotti and Sofía Pérez‐del‐Pulgar. Their work appears in journals such as Journal of Hepatology, Hepatology, Gut, Liver International and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.